JPRN-UMIN000009822
Recruiting
Phase 2
Randomized phase II trial of neoadjuvant Chemotherapy with Gemcitabine and S-1 vs. without neoadjuvant chemotherapy in patients with resectable pancreatic cancer - Randomized phase II trial of GS neoadjuvant therapy for patients with resectable pancreatic cancer (CAP-004)
Chiba study group of adjuvant chemotherapy for pancreatic cancer0 sites74 target enrollmentJanuary 20, 2013
ConditionsResectable pancreatic cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Resectable pancreatic cancer
- Sponsor
- Chiba study group of adjuvant chemotherapy for pancreatic cancer
- Enrollment
- 74
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Inadequate physical condition for gemcitabine or S\-1 treatmetn according to manufacture's instruction 2\. Sever myelosuppression 3\. Pregnancy, breast feeding, or women who desire to preserve fecundity 4\. Sever renal dysfunction 5\. Sever hepatic dysfunction 6\. With other anticancer treatment 7\. With flucitocine or warfarin potassium treatment 8\. With pulmonary fibrosis 9\. With history of radiation to lung field 10\. Active infectious disease 11\. Massive pleural effusion 12\. With distant metastasis 13\. Active malignancies other than pancreatic cancer 14\. Severe angina, cardiac infurction within 3 months at the registration, and severe hear failure 15\. Severe diabetes or hypertension 16\. Severe mental disorder 17\. Inadequate physical condition, as diagnosed by primary physician
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Bintrafusp alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma.retroperitoneal sarcomasMedDRA version: 20.0Level: LLTClassification code 10039494Term: Sarcoma NOSSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10077289Term: Retroperitoneal sarcomaSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2021-001085-37-FRInstitut Bergonié66
Completed
Not Applicable
Randomized phase II study of neoadjuvant chemotherapy with or without letrozole for postmenopausal ER-positive/HER2-negative breast cancersPostmenopausal breast cancerJPRN-UMIN000008416Kobe Breast Cancer Oncology Group70
Completed
Phase 2
Randomized Phase II Study of Neoadjuvant Chemotherapy and Trastuzumab (Herceptin) for Operable Breast Cancer with Overexpression of HER2Breast CancerJPRN-UMIN000000651Office for cordination of Herceptin trial100
Completed
Phase 2
A randomized phase II trial of adjuvant Chemotherapy with Gemcitabine alone, S-1 alone, versus gemcitabine and S-1 in patients with resected pancreatic cancerIncasive ductal carcinoma of pancreas with macroscopic complete resectionJPRN-UMIN000002000Chiba study group of adjuvant chemotherapy for pancreatic cancer96
Completed
Phase 2
A randomized phase II trial of adjuvant chemotherapy with UFT/LV versus S-1 following curative resection for stage III colorectal cancerstage III colorectal cancerJPRN-UMIN000001560Boso Clinical Oncology Group140